Pilot trial of paclitaxel-Herceptin [trastuzumab] adjuvant therapy for early stage breast cancer
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Paclitaxel (Primary) ; Trastuzumab (Primary) ; Cyclophosphamide; Doxorubicin; Tamoxifen
- Indications Breast cancer
- Focus Adverse reactions
- 01 Dec 2015 Results published in the British Journal of Cancer
- 22 Dec 2006 Status change
- 27 Sep 2005 New trial record.